The Trump Administration finalized a rule that restricts medical frailty exemptions from the Medicaid work requirement enacted in the 2025 reconciliation law. The rule narrows exemptions for blindness, disability, substance use disorder, disabling mental disorders, and physical, intellectual, or developmental disabilities that impair ability to perform daily activities. The work requirement takes Medicaid coverage from enrollees who do not meet the requirement and do not qualify for an exemption. The rule is now in effect following finalization.
Why it mattersMedicaid MCOs will face increased disenrollment of members who cannot meet work requirements or qualify for narrowed medical exemptions, affecting revenue, medical loss ratios, and administrative burden related to exemption verification and member appeals.
Managed Care
Senate Democrats Ron Wyden and Maggie Hassan have launched an investigation into Health Secretary Robert F. Kennedy Jr.'s restructuring of the Advisory Committee on Immunization Practices (ACIP), the federal panel that issues vaccine recommendations. The senators are demanding communications and records showing who determined the legal and public health consequences of remaking the advisory committee. ACIP recommendations typically inform Medicaid and CHIP coverage decisions for vaccines under the Vaccines for Children program and mandatory coverage requirements for pediatric vaccines. The investigation seeks transparency around the decision-making process that led to changes in the federal vaccine policy infrastructure.
Why it mattersChanges to ACIP composition or process could affect vaccine coverage mandates for Medicaid and CHIP enrollees, particularly the Vaccines for Children program that provides federally funded vaccines to Medicaid-eligible children.
CHIP · Managed Care
The CDC reported nitazene-involved overdose deaths increased from 27 in 2020 to 409 in 2024, marking a 1,415% rise in confirmed fatalities from these super-potent synthetic opioids. Nitazenes are spreading across the U.S. drug supply, often mixed with or sold as other substances. The sharp escalation indicates an emerging public health threat requiring enhanced overdose response capacity. This trend follows patterns seen with fentanyl's emergence in the illicit drug market over the past decade.
Why it mattersMedicaid managed care organizations may face increased emergency department utilization, overdose response costs, and need for expanded medication-assisted treatment capacity as nitazenes spread through their service areas.
Behavioral Health · Managed Care
CMS issued a request for information on pharmacy benefit manager compensation structures and business practices to inform implementation of new legislative requirements. The RFI focuses on two mandates taking effect in 2028: restrictions on remuneration PBMs and affiliates may receive for services related to Part D drug utilization, and new data reporting requirements. CMS is seeking technical input on PBM service arrangements, affiliate relationships, and compensation models. Comments will shape how CMS defines permissible PBM compensation and structures data collection requirements for Medicare Part D plans.
Why it mattersMedicaid managed care organizations with integrated Part D plans or pharmacy benefit arrangements structured similarly to Medicare will need to monitor the resulting compensation restrictions and reporting requirements, as state Medicaid programs increasingly scrutinize PBM arrangements and may adopt parallel transparency and compensation limitations.
Pharmacy · Managed Care